feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of gm1-gangliosidosis
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of gm1-gangliosidosis

;Yuki Maeda;Keiichi Motoyama;Taishi Higashi;Yuka Horikoshi;Toru Takeo;Naomi Nakagata;Yuki Kurauchi;Hiroshi Katsuki;Yuki Kondo;Yoichi Ishitsuka;Tetsumi Irie;Takumi Era;Hidetoshi Arima
topics in organometallic chemistry 2016 Vol. 11 pp. 183-184
179
maeda2016asianfeasibility

Keywords

fibroblasts pharmacology cyclodextrins

Access

DOI:
10.1016/j.ajps.2015.11.046
URL:
http://www.sciencedirect.com/science/article/pii/S...

Citation

ID: 202515
Ref Key: maeda2016asianfeasibility
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
202515
Unique Identifier:
10.1016/j.ajps.2015.11.046
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store